BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Malignancy Cancer

Below is an extended Malignancy Cancer research listing. Click here to return to the Malignancy Cancer main in depth entry.

Recent Publications on Malignancy Cancer:

Expression transformation of claudin-1 in the process of gastric adenocarcinoma invasion. 30th August, 2008
Department of Pathology, the First Affiliated Hospital of Fujian Medical
Clinical, genetic, and histopathologic investigation of HRPT2-related familial hyperparathyroidism.
HRPT2 germline mutations are responsible for more than half of cases of...
Direct Link
30th August, 2008
G Masi, IRCSS Istituto Oncologico Veneto, Padova, Italy.
Peripheral T-cell lymphoma not otherwise-specified: the stuff of genes, dreams and therapies.
Peripheral T-cell lymphomas (PTCLs) account for about 12% of lymphoid...
Direct Link
30th August, 2008
Department of Haematology and Clinical Oncology "L. and A. Seragnoli",
The osmotic tissue expander: a three-year clinical experience.
Closure of defects after trauma or excision of neoplasms is a basic skill...
Direct Link
30th August, 2008
University Medical Center Groningen, University of Groningen, Department
Fine needle aspiration biopsy: Role in diagnosis of pediatric head and neck masses.
OBJECTIVE: To assess the feasibility and role of fine needle aspiration...
Direct Link
30th August, 2008
Department of Pediatric Otolaryngology, Children's Hospital of Pittsburgh,
Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma.
Soluble forms of major histocompatibility complex (MHC) class I-related...
Direct Link
30th August, 2008
Department of Gastroenterology and Hepatology, Osaka University Graduate
Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2.
Lysophosphatidic acid (LPA) is one of the simplest natural phospholipids....
Direct Link
30th August, 2008
Department of Internal Medicine and Molecular Therapeutics, Institute of
Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis.
Head and neck cancer (HNC) is one of the 10 most frequent cancers...
Direct Link
30th August, 2008
Graduate Institute of Biomedical Science, Chang Gung University, 259
[Identification of two potential serum biomarkers for ovarian cancer and clinical validation thereof] 30th August, 2008
Department of Women Neoplasms, Cancer Hospital, Guangxi Medical
A case with diffuse uterine leiomyomatosis and review of the literature. 30th August, 2008
Department of Obstetrics and Gynecology, Kahramanmaras Sutcu Imnam
Association of Fas-670 gene polymorphism with risk of cervical cancer in North Indian population. 30th August, 2008
Department of Biotechnology, Panjab University, Chandigrah, India.
Genetic complexity of myeloproliferative neoplasms.
Oncogenic mutations in JAK2 and MPL genes have recently been identified in...
Direct Link
30th August, 2008
[1] 1Center for Molecular Medicine (CeMM), Austrian Academy of Sciences,
Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs).
The frequency of cytogenetic abnormalities in the Philadelphia-negative...
Direct Link
30th August, 2008
1Department of Haematology, Royal Hallamshire Hospital, Sheffield, UK.
JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science.
Although it has long been known that the myeloproliferative neoplasms...
Direct Link
30th August, 2008
1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer
Distinguishing Breast Carcinoma From Mullerian Serous Carcinoma With Mammaglobin and Mesothelin.
Differentiation of Mullerian serous carcinoma from metastatic breast...
Direct Link
30th August, 2008
Department of Pathology, University of Virginia Health System,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional